From black coffee to a hair of the dog – here’s the science behind popular hangover remedies.
Academic rigor, journalistic flair
Articles on Drugs
Displaying 221 - 240 of 454 articles
Many people may misunderstand the basics about opioids. That prevents researchers from understanding the full scope of the epidemic.
Psychotropic medication is ‘pharmaceutical violence’ against migrant children and other incarcerated youth throughout the United States. Drug addiction is one consequence.
We’ve got better at managing the health risks of traditional drugs of abuse, but novel psychoactive substances, or ‘legal highs’, are a dangerous unknown.
Naloxone programmes have sprung up in the UK and elsewhere, but drug death rates keep climbing.
It’s time Health Canada took back the regulation of drug advertising – to protect consumers.
Many people aren’t just taking one drug but a combination of drugs.
The opioid crisis in the US has quadrupled the number of babies born addicted to drugs.
Drugs are finding their way into lakes and rivers, and we need to know exactly what they’re doing to wildlife.
An April 2017 survey explored Americans’ opinions about government intervention and welfare policies. It found that on average, they want more from their government, but are highly polarised.
Medical cannabis in the UK? Don’t hold your breath.
New research in North Yorkshire has found most police officers are keen not to criminalise cannabis users.
The Canadian government must undertake regular analysis of the drug shortage problem, if we are ever to develop sustainable solutions.
Ginsberg was one of the most high-profile representatives of the American counterculture and anti-war movement.
Most countries need to find a happy balance between the American attitude that all pain needs to be cured – and the ethos in other countries that pain is to be endured.
Students used to take drugs to get high, now they are using them to get better grades.
The Home Office has announced a review of the law around medical cannabis in Britain – so what does the law say?
In today’s opioid crisis, why are some people with addictions treated with empathy and others with disdain? The answer to that question has roots in the 19th century.
The US is currently short on 182 drugs and medical supplies. The problem isn’t new, but it’s frustrating health care workers.
In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Senior Lecturer of Addiction, Edith Cowan University
-
Professor in Substance Use, Liverpool John Moores University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Vice Chancellor’s Senior Research Fellow, Social Equity Research Centre and Digital Ethnography Research Centre, RMIT University
-
Associate Professor of the School of Pharmacy, University of Sydney
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
University of Sydney
-
Lecturer, RMIT University
-
Senior Lecturer in Chemistry, University of Birmingham
-
PhD Candidate, Royal Holloway University of London
-
Senior Lecturer in Criminology, Deakin University
-
Professor & Specialist in Drug Policy, UNSW Sydney
